Features

  • Executing buy and build in pharma services

    By McDermott Will & Emery Investors continue to flock to pharma services, targeting opportunities across the range of providers to the biopharmaceutical industry that can cover everything from preclinical development and clinical trials to manufacturing, distribution and commercialisation. According to Pitchbook data, there were 774 private equity deals in pharma services in the three years [...]

  • How to make your medical education sync with your marketing

    By Bethany Lowes Bush, Associate Director, at EatMoreFruit Communications Most Healthcare professionals need 50 Continuous Professional Development (CPD) credits annually in the UK, and up to 150 Continuous Medical Education (CME) credits in some US specialties and CME cycles.  When done right, these sessions inspire new research and improve patient care. Whether it's new trial [...]

  • Talent management in health tech: Attracting and retaining top innovators

    Odgers Berndtson’s Chris Hamilton and Mike Drew, provide a guide to finding and keeping top health tech leaders The health tech sector is at the forefront of transforming healthcare through technology, requiring leaders that combine expertise in advanced fields like AI, data analytics, and healthcare systems. For companies operating in this dynamic space, identifying, attracting, [...]

  • A vision for a unified health data platform

    By Ruth Holland, Director of Data & Analytics, London Secure Data Environment, OneLondon Health Data Portfolio, and Mark Kewley,  Programme Director, London Secure Data Environment, OneLondon Health Data Portfolio. The landscape of healthcare is increasingly being shaped by the effective use of data, yet the journey towards realising the full potential of NHS data is [...]

  • Private GP services: What to expect

    Healthcare in 2025 faces unique challenges, with NHS waiting lists exceeding 7.5 million patients. For many, these delays can lead to weeks or even months of waiting for consultations or treatments. This has driven a significant shift toward private GP services, offering faster access to care, more personalised treatment, and a level of flexibility that [...]

  • Embracing AI in healthcare: Striking the balance between innovation and responsibility

    By Philippa Kirkpatrick, Chief Digital Information Officer, South East London ICB Ahead of her presentation at Digital Health Rewired 2025 in the "Raising the digital skills of the whole NHS workforce" session on the Leadership and Teams stage, Philippa Kirkpatrick, Chief Digital Information Officer at South East London Integrated Care Board (ICB), reflects on the [...]

  • Health tech leadership trends 2025

    Odgers Berndtson’s Chris Hamilton and Mike Drew, look at the top five health tech leadership hiring trends they expect to play out next year The health tech industry is at a transformative crossroads, driven by rapid advancements in technology and an evolving healthcare landscape. As we look ahead to 2025, health tech leaders must prepare to navigate a [...]

  • Will AI be the answer to rescuing health and social care from admin burnout?

    By Dr Jonathan Shaw, former surgeon and emergency physician and Clinical Director at System C Lord Darzi's independent review of the NHS paints a sobering picture of an overburdened system straining under the weight of escalating demands. He highlighted how the service is in a ‘critical condition’ with issues around efficiency and access to services. [...]

  • Sponsored: GI Genius enters NAIAD large-scale clinical trial

    Early detection is crucial for effective treatment of colorectal cancer, but the initial stages are  easily missed during endoscopy screenings. With GI Genius, Medtronic presents an AI-powered tool to help detect precancerous lesions in real-time. In an upcoming large-scale trial, the intelligent endoscopy module will demonstrate its benefit in the clinical context.   Colorectal cancer is [...]

  • EU enforces stricter liability for life sciences products

    Written by Vladimir Murovec, Head of Life Sciences Regulatory, Osborne Clarke in Brussels The European Union has introduced a new product liability directive, replacing the previous directive 85/374/EEC, to address modern technological advancements and bolster consumer protection. Effective December 2026, the legislation seeks to harmonise liability standards across the EU, compelling pharmaceutical and medical device companies [...]